Viemed Healthcare, Inc.
VMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 22.5% | 31.8% | 18.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.4% | 61.6% | 61% | 62.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.9% | 20% | 17.9% | 20.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5% | 5.6% | 4.5% | 7.8% |
| EPS Diluted | 0.28 | 0.25 | 0.15 | 0.22 |
| % Growth | 12% | 66.7% | -31.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |